News
A new study published in the medical journal JAMA has raised some concerns for people with atrial fibrillation, a condition ...
On CNBC's "Mad Money Lightning Round," Jim Cramer praised home improvement retailer Lowe's Companies and CrowdStrike Holdings ...
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
New meta-analysis finds oral anticoagulants reduce net adverse events in patients with atrial fibrillation after intracranial hemorrhage but with a higher risk for recurrent intracranial hemorrhage.
5d
MedPage Today on MSNHeart Attack Mix-Ups; New Transplant Risk Score; Discounted Direct-to-Patient DOAC
Even in people with normal BMI, visceral obesity could be tied to greater aortic stiffness and elevated risk of ...
I had a complete hysterectomy in my late 40s due to endometriosis. I am now 68 and have been on 0.1-mg patches of estradiol ...
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...
I have low serum cholesterol but a high coronary calcium score, and I was told to take magnesium supplements to bring my ...
The global market for anticoagulants treating cancer-associated thrombosis is growing steadily. Valued at around billion in 2 ...
4d
Clinical Trials Arena on MSNInterVene’s thrombectomy catheter success in first-in-human case
The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results